0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Hematology
 41-60 of 277 Articles
Medical News and Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2013;309(2):124-125. doi:10.1001/jama.2012.116881.

JAMA Clinical Evidence Synopsis | 
Jeffrey L. Carson, MD; Paul A. Carless, MMedSc (Clin Epid); Paul C. Hébert, MD, MSc
JAMA. 2013;309(1):83-84. doi:10.1001/jama.2012.50429.

Editorial |  FREE
Mary McGrae McDermott, MD; Edward H. Livingston, MD
JAMA. 2013;309(1):89. doi:10.1001/jama.2012.148063.

JAMA Clinical Challenge | 
Javier Munoz, MD; Philip Kuriakose, MD
JAMA. 2012;308(22):2399-2400. doi:10.1001/jama.2012.91077.

Viewpoint | 
Robert Hromas, MD; Janis L. Abkowitz, MD; Armand Keating, MD
JAMA. 2012;308(22):2343-2344. doi:10.1001/jama.2012.45067.

Original Contribution |  FREE
Paul A. Gurbel, MD; David Erlinge, MD; E. Magnus Ohman, MB, ChB; et al.
JAMA. 2012;308(17):1785-1794. doi:10.1001/jama.2012.17312.
Includes: Supplemental Content

Global Health | 
M. J. Friedrich
JAMA. 2012;308(15):1515. doi:10.1001/jama.2012.13775.

JAMA Patient Page |  FREE
Denise M. Goodman, MD, MS; Alison E. Burke, MA; Edward H. Livingston, MD
JAMA. 2012;308(14):1492. doi:10.1001/jama.2012.4089.
Includes: Supplemental Content

Original Contribution |  FREE
Carolyn R. Broderick, MBBS; Robert D. Herbert, PhD; Jane Latimer, PhD; et al.
JAMA. 2012;308(14):1452-1459. doi:10.1001/jama.2012.12727.
Includes: Supplemental Content

Editorial | 
Marilyn J. Manco-Johnson, MD
JAMA. 2012;308(14):1480-1481. doi:10.1001/jama.2012.13303.

Original Contribution |  FREE
Dean A. Fergusson, MHA, PhD; Paul Hébert, MD, MHSc(Epid); Debora L. Hogan, BScN, BA, MScN; et al.
JAMA. 2012;308(14):1443-1451. doi:10.1001/2012.jama.11953.
Includes: CME, Supplemental Content

Original Contribution |  FREE
LCDR Thomas Q. Gallagher , MC, USN; Courtney Hill, MD; Shilpa Ojha, MBChB; et al.
JAMA. 2012;308(12):1221-1226. doi:10.1001/2012.jama.11575.
Includes: Supplemental Content

Editorial | 
Kimberly F. Whelan, MD, MSPH; Frederick D. Goldman, MD
JAMA. 2012;307(24):2639-2641. doi:10.1001/jama.2012.6975.

JAMA Clinical Challenge |  FREE
Robert Micheletti, MD; Misha Rosenbach, MD
JAMA. 2012;307(24):2635-2636. doi:10.1001/jama.2012.4302.

JAMA Patient Page |  FREE
Janet M. Torpy, MD; Cassio Lynm, MA; Robert M. Golub, MD
JAMA. 2012;307(22):2448. doi:10.1001/jama.2012.6179.
Includes: Supplemental Content

Medical News & Perspectives | 
Bridget M. Kuehn
JAMA. 2012;307(17):1788-1789. doi:10.1001/jama.2012.3728.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2012;307(17):1793-1795. doi:.

JAMA Masthead |  FREE
JAMA. 2012;307(17):1777-1778. doi:10.1001/jama.307.17.1777.

Clinical Crossroads Update | 
Amy N. Ship, MD; Neha S. Trivedi, BS
JAMA. 2012;307(13):1430. doi:10.1001/jama.2012.411.

Research Letters |  FREE
Alem Mehari, MD; Mark T. Gladwin, MD; Xin Tian, PhD; et al.
JAMA. 2012;307(12):1254-1256. doi:10.1001/jama.2012.358.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Dermatology
Observation  | 
Cutaneous Hemophagocytosis After Alemtuzumab Injection in a Patient With Sézary Syndrome
Sarah I. Jawed, BA; Klaus Busam, MD; Xuan Wang, MD, PhD; et al.
JAMA Dermatology
Case Report/Case Series  | 
Mucocutaneous Granulomatous Disease in a Patient With Hermansky-Pudlak Syndrome
Heather L. Salvaggio, MD; Kristen E. Graeber, BS; Loren E. Clarke, MD; et al.
JAMA Dermatology
Original Investigation  | 
Outcomes After Diagnosis of Mycosis Fungoides and Sézary Syndrome Before 30 Years of Age:  A Population-Based Study
Weiyun Z. Ai, MD, PhD; Theresa H. Keegan, PhD, MS; David J. Press, MPhil; et al.
JAMA Dermatology
Research Letter  | 
Alemtuzumab Therapy for Leukemic Cutaneous T-Cell Lymphoma:  Diffuse Erythema as a Positive Predictor of Complete Remission
Rei Watanabe, MD, PhD; Jessica E. Teague, PhD; David C. Fisher, MD; et al.